Addictive disorders are chronic, relapsing conditions that cause extensive disease burden. Genetic factors partly account for susceptibility to addiction, but environmental factors such …
Abstract Alzheimer's disease (AD), a neurodegenerative condition previously known to affect the older population, is also now seen in younger individuals. AD is often associated with …
K Ebner, SB Sartori, N Singewald - Current pharmaceutical …, 2009 - ingentaconnect.com
The first report demonstrating the therapeutic efficacy of an orally applied neurokinin-1 (NK1) receptor antagonist in depression was published 10 years ago. Although there were …
JR Schank, M Heilig - International review of neurobiology, 2017 - Elsevier
Substance P (SP) is an 11-amino acid neuropeptide of the tachykinin family that preferentially activates the neurokinin-1 receptor (NK1R). First isolated 85 years ago and …
K Ebner, P Muigg, G Singewald… - Annals of the New York …, 2008 - Wiley Online Library
In a previous work it was demonstrated that emotional stressors trigger the in vivo release of the neuropeptide substance P (SP) in brain areas known to be implicated in stress and …
Adult neurogenesis has been implicated in affective disorders and the action of antidepressants (ADs) although the functional significance of this association is still unclear …
Rationale Genetic inactivation or pharmacological antagonism of neurokinin 1 (NK1) receptors blocks morphine and alcohol reward in rodents, while NK1 antagonism decreases …
The medial nucleus of the amygdala (MeA) is a complex component of the “extended amygdala” in rats. Its posterodorsal subnucleus (MePD) has a remarkable expression of …
CA Boyle, B Hu, KL Quaintance… - The Journal of …, 2022 - Wiley Online Library
The tachykinin peptides include substance P (SP), neurokinin A and neurokinin B, which interact with three G‐protein‐coupled neurokinin receptors, NK1Rs, NK2Rs and NK3Rs …